The Promise of PD1 Inhibitors in Kidney Cancer

GRACEcast Lung Cancer Video by cancerGRACE - H. Jack West, MD

Results from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.

Related Episodes

Continue listening to more episodes from GRACEcast Lung Cancer Video.

Jul 31, 2014 - 04:36

Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung canc...

Jul 29, 2014 - 01:55

What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for...

Jul 27, 2014 - 05:28

The doctors discuss the circumstances under which small cell lung cancer patients should receive prophyla...

Jul 24, 2014 - 02:03

NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and,...

Jul 22, 2014 - 02:27

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lu...

Jul 20, 2014 - 04:40

Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer pa...

Jul 17, 2014 - 07:28

The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab...

Jul 15, 2014 - 03:15

Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and h...